Matteo Bassetti

Active 1984–2026

384
Papers
43,435
Citations
109
h-index
341
i10-index

Citations

Citations per year for Matteo Bassetti1980: 1 citations1990: 2 citations1994: 2 citations2000: 1 citations2001: 3 citations2002: 7 citations2003: 5 citations2004: 2 citations2005: 4 citations2006: 7 citations2007: 10 citations2008: 10 citations2009: 18 citations2010: 25 citations2011: 29 citations2012: 51 citations2013: 128 citations2014: 195 citations2015: 185 citations2016: 267 citations2017: 262 citations2018: 238 citations2019: 1,178 citations2020: 1,658 citations2021: 2,318 citations2022: 2,172 citations2023: 1,666 citations2024: 2,740 citations2025: 1,329 citations2026: 38 citations1981–1989: no citations, so these years are not shown1991–1993: no citations, so these years are not shown1995–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,607 citing papers, 14.8% of this breakdownItaly: 1,481 citing papers, 8.4% of this breakdownChina: 1,295 citing papers, 7.3% of this breakdownFrance: 914 citing papers, 5.2% of this breakdownSpain: 874 citing papers, 4.9% of this breakdownUnited Kingdom: 872 citing papers, 4.9% of this breakdownGermany: 732 citing papers, 4.1% of this breakdownAustralia: 648 citing papers, 3.7% of this breakdownNetherlands: 486 citing papers, 2.8% of this breakdownIndia: 483 citing papers, 2.7% of this breakdownGreece: 430 citing papers, 2.4% of this breakdownBrazil: 403 citing papers, 2.3% of this breakdown
0%14.8%Other 36.5%

Fields

  • Medicine57.8%
  • Biochemistry, Genetics and Molecular Biology29%
  • Immunology and Microbiology6.4%
  • Environmental Science1.3%
  • Agricultural and Biological Sciences1.1%
  • Engineering0.7%
  • Other3.7%

Topics

  • Antibiotic Resistance in Bacteria10.9%
  • Antifungal resistance and susceptibility7.4%
  • Antibiotics Pharmacokinetics and Efficacy7%
  • Antibiotic Use and Resistance5.7%
  • Fungal Infections and Studies4.9%
  • Nosocomial Infections in ICU3.5%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 cited by 995

  3. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 792

  4. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

    Authors: , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 cited by 1,049

  5. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 953

  6. Bloodstream infections in critically ill patients: an expert statement

    Authors: , , , , - Intensive Care Medicine 2020 cited by 454

  7. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konstantina Katrini, Vasilios Kotsis, George Tsoukalas, Carlo Selmi, Ioannis A. Bliziotis, Michael Samarkos, Michael Doumas, Sofia Ira Ktena, Aikaterini Masgala, Ιlias Papanikolaou, Maria Kosmidou, Dimitra-Melia Myrodia, Aikaterini Argyraki, Chiara Simona Cardellino, Katerina Koliakou, Eleni-Ioanna Katsigianni, Vassiliki Rapti, Efthymia Giannitsioti, Antonella Cingolani, Styliani Micha, Karolina Akinosoglou, Orestis Liatsis-Douvitsas, Styliani Symbardi, Nikolaos Gatselis, Maria Mouktaroudi, Giuseppe Ippolito, Eleni Florou, Antigone Kotsaki, Mihai G. Netea, Jesper Eugen‐Olsen, Miltiades Kyprianou, Periklis Panagopoulos, George Ν. Dalekos, Evangelos J. Giamarellos‐Bourboulis - Nature Medicine 2021 cited by 539

  8. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ben Margetts, Meredith Young, Neeraj Bhadange, Steven Tyler, Anne Ledtischke, Mackenzie Finnis, Anne Ledtischke, Mackenzie Finnis, Jyotsna Dwivedi, Manoj Saxena, Vishwanath Biradar, Natalie Soar, Vineet Sarode, David Brewster, Adrian Regli, Elizabeth Weeda, Samiul Parvez Ahmed, Cheryl Fourie, Kevin B. Laupland, Mahesh Ramanan, James Walsham, Jason Meyer, Edward Litton, Anna Maria Palermo, Timothy A. Yap, Ege Eroglu, Antony Attokaran, C’havala Jaramillo, Khalid Mahmood Khan Nafees, Nurhikmahtul Aqilah Haji Abd Rashid, Haji Adi Muhamad Ibnu Walid, Tomas Mon, P. Dhakshina Moorthi, Shah Sudhirchandra, Dhadappa Damodar Sridharan, Qiu Haibo, Jianfeng Xie, Lu Wei-Hua, Zhen Wang, Chuanyun Qian, Jili Luo, Xiaomei Chen, Hao Wang, Peng Zhao, Juan Zhao, Qiu Wusi, Chen Mingmin, Lei Xu, Chengfen Yin, Ruilan Wang, Jinfeng Wang, Yongjie Yin, Min Zhang, Jilu Ye, Chungfang Hu, Suming Zhou, Min Huang, Jing Yan, Yan Wang, Bingyu Qin, Ling Ye, Xie Weifeng, Li Peije, Nan Geng, Yoshiro Hayashi, Toshiyuki Karumai, Masaki Yamasaki, Satoru Hashimoto, Koji Hosokawa, Junichiro Makino and 615 more - Intensive Care Medicine 2023 cited by 246

  9. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romanee Chaiwarith, Methee Chayakulkeeree, Sharon Chen, Yee‐Chun Chen, Yen‐Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin-Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Hervé Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortün, Julia Garcia‐Diaz, Massimo Girardis, Fang He, Maya Hites, Mao‐Wang Ho, Patrick M. Honoré, Juan Pablo Horcajada, Haihui Huang, Po‐Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jáuregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V. Kern, Daniel H. Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Αναστασία Κοτανίδου, Anne M. Lachiewicz, Qinhan Lin, Luis Eduardo López Cortés, Hong Luo, Roberto Luzzati, ‪Yasmin Maor‬‏, Todd P McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean‐Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Muñoz García de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabaşı, Vasileios Papastamopoulos, David L. Paterson, Thomas F. Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaëtan Plantefève and 42 more - The Lancet 2022 cited by 168

  10. Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniele Roberto Giacobbe, Annalisa Saracino, Massimo Fantoni, Spinello Antinori, Maddalena Peghin, Paolo Bonfanti, Alessandra Oliva, Andrea De Gasperi, Giusy Tiseo, Cristina Rovelli, Marianna Meschiari, Nour Shbaklo, Teresa Spanu, Roberto Cauda, Pierluigi Viale - Clinical Infectious Diseases 2021 cited by 266

  11. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuradha Chowdhary, Sybren de Hoog, George Dimopoulos, Rafael F. Duarte, Petr Hamal, Jacques F. Meis, Sayoki Mfinanga, Flávio Queiroz‐Telles, Thomas F. Patterson, Galia Rahav, Thomas R. Rogers, Coleman Rotstein, Retno Wahyuningsih, Danila Seidel, Oliver A. Cornely - The Lancet Infectious Diseases 2021 cited by 432

  12. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott A. Beatson, Anton Y. Peleg, Tiffany Harris‐Brown, David L. Paterson - JAMA 2018 cited by 770

  13. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 cited by 1,214

  14. DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabio Silvio Taccone, J. Rello, Laura Ruano, Elsa Afonso, Francisco Álvarez-Lerma, M.P. Gracia-Arnillas, F. Fernandez, Nícolas de Albuquerque Pereira Feijóo, N. Bardolet, A Rovira, Pau Garro, Diego Colón, C. Castillo, J. Fernado, María José López, José Luís Fernández, Alfredo Arribas, J. L. Teja, Elsa Ots, Juan Carlos Montejo, M. S. Catalán, I. Prieto, G. Gonzalo, Beatriz Galván, M. A. Blasco, EC Meyer, F. Del Nogal, Loreto Vidaur, Rafael Sebastián, P. M. Garde, M. d. M. Martin Velasco, Rafael Zaragoza, M. Esperatti, A. Torres, P. Montravers, Olivier Baldési, H. Dupont, Yazine Mahjoub, Sigismond Lasocki, Jean-Michel Constantin, Jean‐François Payen, C. Martin, J. Albanèse, Yannick Mallédant, Julien Pottecher, Jean Yves Lefrant, S. Jaber, O. Joannes-Boyau, Carmen Orban, Marlies Ostermann, Cathrine McKenzie, W. R. Berry, Julie Smith, K Lei, Francesca Rubulotta, Anthony Gordon, Stephen J. Brett, M. Stotz, M. Templeton, Andrew Rhodes, Claudia Ebm, Cristiane Aparecida Moran, K.-M. Kaukonen, Ville Pettilä, G. Dimopoulos, Despoina Koulenti, A. Xristodoulou, Vasiliki Theodorou, Georgios Kouliatsis, Eleni Sertaridou and 75 more - Clinical Infectious Diseases 2014 cited by 1,083

  15. How to manage Pseudomonas aeruginosa infections

    Authors: , , , , - Drugs in Context 2018 cited by 746

  16. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2023 cited by 285

  17. Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Infectious Diseases and Therapy 2018 cited by 442

  18. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carolina García‐Vidal, Daniele Roberto Giacobbe, Anna L. Goodman, Petr Hamal, Helena Hammarström, Cristina Toscano, Fanny Lanternier, Cornelia Lass‐Flörl, Deborah Lockhart, Thomas Longval, Laura Loughlin, Tadeja Matos, Małgorzata Mikulska, Manjusha Narayanan, Sonia Martín‐Pérez, Juergen Prattes, Benedict Rogers, Laman Rahimli, Maite Ruiz, Emmanuel Roilides, Michael Samarkos, Ulrike Scharmann, Uluhan Sili, Oğuz Reşat Sıpahı, Alena Siváková, Joerg Steinmann, Janina Trauth, Özge Turhan, Jens Van Praet, Antonio Vena, P. Lewis White, Birgit Willinger, Anna Maria Tortorano, Maiken Cavling Arendrup, Philipp Koehler, Oliver A. Cornely, Mario Tumbarello, Alida Fe Talento, Alba Ruiz‐Gaitán, Zdeněk Ráčil, И. О. Стома, María Calbacho, Eric Van Wijngaerden, Júlia Henriques, Harriett Jordan, Valentina Ferroni, Özlem Koyuncu Özyurt, Christopher Milacek, Robert Krause, Christoph Zurl, Matthijs Backx, Ang Li, Raphael Seufert, Rok Tomazin, Yael Blankenheim, Julio Dávila, Paloma García-Clemente, Tomáš Freiberger, Jochem B. Buil, Jacques F. Meis, Deniz Akyol, Hélène Guegan, Clare Logan - The Lancet Infectious Diseases 2023 cited by 140

  19. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 153

  20. Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2023 cited by 140

  21. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José-Artur Paiva, Maddalena Peghin, Santi Maurizio Raineri, Riina Rautemaa‐Richardson, Jeroen Schouten, Pierluigi Brugnaro, Herbert Spapen, Polychronis Tasioudis, Jean‐François Timsit, Valentino Tisa, Mario Tumbarello, Charlotte H. S. B. van den Berg, Benoît Veber, Mario Venditti, Guillaume Voiriot, Joost Wauters, Philippe Montravers - Critical Care 2019 cited by 253

  22. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Özlem Koyuncu Özyurt, Faruk Aydın, Filip Růžička, Eelco F. J. Meijer, Jean‐Pierre Gangneux, Deborah Lockhart, Nina Khanna, Clare Logan, Ulrike Scharmann, Guillaume Désoubeaux, Emmanuel Roilides, Alida Fe Talento, Karin van Dijk, Philipp Koehler, Jon Salmanton‐García, Oliver A. Cornely, Martin Hoenigl - Journal of Infection 2023 cited by 107

  23. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 cited by 454

  24. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group

    Authors: , , , , , , , - Clinical Infectious Diseases 2021 cited by 293